Johnston PG - Search Results

1

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Among authors: johnston pg. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

2

The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.

Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M, Johnston PG. Longley DB, et al. Among authors: johnston pg. Clin Cancer Res. 2004 May 15;10(10):3562-71. doi: 10.1158/1078-0432.CCR-03-0532. Clin Cancer Res. 2004. PMID: 15161716

3

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

Longley DB, Latif T, Boyer J, Allen WL, Maxwell PJ, Johnston PG. Longley DB, et al. Among authors: johnston pg. Semin Oncol. 2003 Jun;30(3 Suppl 6):3-9. doi: 10.1016/s0093-7754(03)00119-2. Semin Oncol. 2003. PMID: 12802789

4

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, Harkin DP. Quinn JE, et al. Among authors: johnston pg. Cancer Res. 2003 Oct 1;63(19):6221-8. Cancer Res. 2003. PMID: 14559807

5

Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.

Boyer J, McLean EG, Aroori S, Wilson P, McCulla A, Carey PD, Longley DB, Johnston PG. Boyer J, et al. Among authors: johnston pg. Clin Cancer Res. 2004 Mar 15;10(6):2158-67. doi: 10.1158/1078-0432.ccr-03-0362. Clin Cancer Res. 2004. PMID: 15041737

6

5-Fluorouracil: identification of novel downstream mediators of tumour response.

Boyer J, Maxwell PJ, Longley DB, Johnston PG. Boyer J, et al. Among authors: johnston pg. Anticancer Res. 2004 Mar-Apr;24(2A):417-23. Anticancer Res. 2004. PMID: 15152939 Free article.

7

The role of BRCA1 in the cellular response to chemotherapy.

Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. Kennedy RD, et al. Among authors: johnston pg. J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68. doi: 10.1093/jnci/djh312. J Natl Cancer Inst. 2004. PMID: 15547178 Review.

8

Role of genomic markers in colorectal cancer treatment.

Allen WL, Johnston PG. Allen WL, et al. Among authors: johnston pg. J Clin Oncol. 2005 Jul 10;23(20):4545-52. doi: 10.1200/JCO.2005.19.752. J Clin Oncol. 2005. PMID: 16002846 Review.

9

Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

Allen WL, Johnston PG. Allen WL, et al. Among authors: johnston pg. Pharmacogenomics. 2005 Sep;6(6):603-14. doi: 10.2217/14622416.6.6.603. Pharmacogenomics. 2005. PMID: 16143000 Review.

10

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG. McDermott U, et al. Among authors: johnston pg. Cancer Res. 2005 Oct 1;65(19):8951-60. doi: 10.1158/0008-5472.CAN-05-0961. Cancer Res. 2005. PMID: 16204068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters